FMP

FMP

Enter

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) Earnings Report Highlights

- (Last modified: Nov 29, 2024 9:27 AM)

twitterlinkedinfacebook
blog post cover photo

Image credit: Google Images

  • Earnings per Share (EPS) of -0.02, surpassing the estimated EPS of -0.03.
  • Reported revenue was approximately $206,329.46, in line with expectations.
  • Positive financial indicators include a low debt-to-equity ratio of 0.14 and a current ratio of 4.87.

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) is a company focused on developing and selling biological solutions for agriculture. Its flagship product, TerraSante, is a biofertility product aimed at enhancing crop yields. The company operates in a competitive market, with other players also offering innovative agricultural solutions. MGROF trades on the PNK exchange.

On November 26, 2024, MGROF reported its earnings, revealing an earnings per share (EPS) of -0.02, which surpassed the estimated EPS of -0.03. The company's revenue was approximately $206,329.46, aligning with expectations. This performance reflects the initial revenue from TerraSante sales, which amounted to C$279,000, including C$272,000 in deferred revenue.

Despite a negative price-to-earnings (P/E) ratio of -209.88, MGROF's financial metrics show some positive aspects. The debt-to-equity ratio is low at 0.14, indicating limited reliance on debt. Additionally, the current ratio of 4.87 suggests a strong ability to meet short-term obligations, providing a cushion for the company as it navigates its growth phase.

Analysts at Noble Capital are optimistic about MGROF's future, projecting a significant increase in TerraSante sales for 2025. They expect fourth-quarter revenue to be around C$25,000, with a target of C$625,000 for fiscal 2025. This growth is anticipated as the company secures more state approvals, expanding its market reach.

The enterprise value to sales ratio of 18.00 and the price-to-sales ratio of 18.88 indicate that investors are willing to pay a premium for MGROF's sales, reflecting confidence in its growth potential. However, the enterprise value to operating cash flow ratio is significantly negative at -453.31, highlighting challenges in generating cash flow.

Other Blogs

May 14, 2024 11:41 AM - Sanzhi Kobzhan

The easiest way to calculate stock’s target price and why the target price is important.

A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...

blog post title

May 24, 2024 9:30 AM - Rajnish Katharotiya

How to Access and Analyze Earnings Call Transcripts

Earnings call transcripts are invaluable resources for investors, analysts, and financial enthusiasts. They provide insights into a company's performance, strategy, and future outlook, making them essential for making informed investment decisions. With Financial Modeling Prep, Earnings Call Transcr...

blog post title

May 27, 2024 3:30 PM - Rajnish Katharotiya

The best 5 GPU stocks other than NVDA

In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...

blog post title
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep